ResearcherInsermActive in the last 2 years

Jean‐Pierre Tasu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8144-5110; OpenAlex author ID A5061787731. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study. Co-author DOI 10.1007/s00330-024-10613-x ↗
Irreversible Electroporation for Locally Advanced Pancreatic Cancer: Where Do We Stand in 2017? Co-author DOI 10.1097/mpa.0000000000000793 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

David Tougeron · 2 shared papers, 2017–2024 · strength 0.27
- Paper Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the… DOI 10.1007/s00330-024-10613-x ↗
- Paper Irreversible Electroporation for Locally Advanced Pancreatic Cancer: Where Do We Stand in 2017? DOI 10.1097/mpa.0000000000000793 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.